ArticleTranslational psychiatry2026

SHANK3 and beta-synuclein are novel blood-based biomarkers for the Phelan-McDermid Syndrome: a pilot study.

Jessica Pagano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.